<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0345">
 <element-citation publication-type="journal" id="h0345">
  <person-group person-group-type="author">
   <name>
    <surname>Kortüm</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Campregher</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Lang</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Khare</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Pinter</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Evstatiev</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Schmid</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Mittlböck</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Scharl</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kucherlapati</surname>
    <given-names>M.H.</given-names>
   </name>
   <name>
    <surname>Edelmann</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Gasche</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice</article-title>
  <source>Gut</source>
  <volume>64</volume>
  <issue>12</issue>
  <year>2015</year>
  <fpage>1905</fpage>
  <lpage>1912</lpage>
  <pub-id pub-id-type="pmid">25429050</pub-id>
 </element-citation>
</ref>
